Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than $20 billion in a deal that would further expand Gilead's portfolio of cancer treatments, the Wall Street Journal reported on Saturday.
FILE PHOTO: Gilead Sciences Inc pharmaceutical company is seen after they announced a Phase 3 Trial of the investigational antiviral drug Remdesivir in patients with severe coronavirus disease , during the outbreak of the coronavirus disease , in Oceanside, California, U.S., April 29, 2020. REUTERS/Mike Blake
A deal for Immunomedics, whose cancer therapy Trodelvy is FDA-approved as a third-line treatment for an aggressive type of breast cancer called Metastatic Triple-Negative Breast Cancer, could be announced Monday if not sooner, the Journal said, citing people familiar with the matter.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
WSJ News Exclusive | Gilead Nears Deal to Buy Immunomedics for More Than $20 BillionGilead Sciences is nearing a deal to buy biotech Immunomedics Inc. and its prized breast-cancer drug for more than $20 billion, according to people familiar with the matter.
Weiterlesen »
WSJ News Exclusive | Gilead Nears Deal to Buy Immunomedics for More Than $20 BillionGilead Sciences is nearing a deal to buy biotech Immunomedics Inc. and its prized breast-cancer drug for more than $20 billion, according to people familiar with the matter.
Weiterlesen »
Nvidia nears deal to buy chip designer Arm for more than $40 billion - sourcesNvidia Corp is close to a deal to buy British chip designer Arm Holdings from SoftBank Group Corp for more than $40 billion in a deal which would create a giant in the chip industry, according to two people familiar with the matter.
Weiterlesen »
Nvidia nears deal to buy chip designer Arm for more than $40 billion - sourcesNvidia Corp is close to a deal to buy British chip designer Arm Holdings from SoftBank Group Corp for more than $40 billion in a deal which would create a giant in the chip industry, according to two people familiar with the matter.
Weiterlesen »
SoftBank nears deal to sell Arm Holdings to Nvidia for more than $40 billion - WSJSoftBank Group Corp is nearing a deal to sell British chip designer Arm Holdings to Nvidia Corp for more than $40 billion, the Wall Street Journal reported on Saturday, citing sources.
Weiterlesen »
WSJ News Exclusive | SoftBank Nears $40 Billion Deal to Sell Arm Holdings to NvidiaThe Japanese technology conglomerate is nearing another big asset sale—a deal selling Arms Holdings to Nvidia for more than $40 billion, according to people familiar with the matter.
Weiterlesen »